Dr. Richard T. Lee
Medical Oncologist, Hematologist Oncologist · Gastrointestinal Cancers, Thoracic Cancers, Urological Cancers, Hematologic CancersDr. Richard Lee, MD, is a board-certified medical oncologist specializing in gastrointestinal cancers, with a focus on liver, bile duct, pancreatic, and colorectal malignancies. He serves as Director of the Gastrointestinal Medical Oncology Program at City of Hope Orange County and holds an academic appointment within City of Hope’s comprehensive cancer research and care network. Dr. Lee earned his medical degree from the University of Minnesota Medical School, completed his residency in internal medicine at Stanford University, and pursued fellowship training in hematology and oncology at the University of Southern California. He is board-certified in Internal Medicine, Hematology, and Medical Oncology.
Dr. Lee is recognized for his commitment to advancing cancer care through personalized medicine, targeted therapies, and clinical research. He has led and contributed to clinical trials focused on improving outcomes for patients with advanced GI malignancies, emphasizing innovative treatment combinations, immunotherapy, and molecularly guided interventions. His research interests also include quality-of-life outcomes and cancer prevention strategies. He has published in peer-reviewed journals and collaborates with multidisciplinary teams to provide evidence-based, patient-centered care within academic and community settings.
In addition to his clinical and research leadership, Dr. Lee is an active contributor to medical education and professional development. He mentors trainees and junior physicians and is involved in national oncology organizations such as the American Society of Clinical Oncology. Through his dedication to translational research, academic mentorship, and the expansion of high-quality cancer care, Dr. Lee plays a vital role in shaping the future of gastrointestinal oncology.
Education
Medical School:
George Washington University
Residency:
Internal Medicine at Stanford University
Fellowship:
Hematology and Oncology, University of Chicago
Palliative Medicine, Northwestern University, Chicago
Board Certification:
Medical Oncology
Medical Oncology
Hospice and Palliative Medicine
Awards
- ASCO Leadership Development Program
- Doris Deford Speck Award, George Washington University Medical Center
- NIH K23 Career Development Award in Integrative Oncology
- Young Investigator Award, American Society of Clinical Oncology – Gastrointestinal Cancers Symposium
- Fellowship Grant, Society for Integrative Oncology
- ASCO Cancer Foundation Young Investigator Awards, American Society of Clinical Oncology
- Lamport Award, George Washington University Medical Center
- Midwest Trainee Travel Award, Clinical Society for Clinical Research
Memberships and affiliations
- American Academy of Hospice and Palliative Medicine
- American Society of Clinical Oncology
- Society for Integrative Oncology
- Department of Supportive Care Medicine, City of Hope Comprehensive Cancer Center
Research and publications
- Retrospective Outcomes of a New Acupuncture Service at a Comprehensive Cancer Center.
- Integrative Oncology and the Clinical Care Network: Challenges and Opportunities.
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling.
- Are NCI Cancer Centers Providing Adolescents and Young Adults With Cancer Focused Clinical Services? A National Survey.
- Mistletoe lectin inhibits growth of Myc-amplified small-cell lung cancer.
- Associations between symptoms with healthcare utilization and death in advanced cancer patients.
- Proposed Implementation of a Patient-Centered Self-Assessment Tool for Patients with Neuroendocrine Tumors among Academic and Community Practice Sites: The City of Hope Model.
- Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline.
Clinical trials
Other medical oncologist, hematologist oncologist listed alphabetically, never by payment.
Browse all doctors →Open trials for these cancers, with the eligibility rules written in plain language.
Search trials →